UHRF1 confers radioresistance to human breast cancer cells

International Journal of Radiation Biology

Volumn 87, Issue 3, 2011, Pages 263-273

  Li, Xinli ^a   Meng, Qinghui ^b   Rosen, Eliot M ^b   Fan, Saijun ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

breast cancer; radiosensitivity; UHRF1

Indexed keywords

COMPLEMENTARY DNA; HOMEODOMAIN PROTEIN; KU ANTIGEN; LIPOCORTIN 5; PROTEIN BAX; RING FINGER PROTEIN; SMALL INTERFERING RNA; UBIQUITIN LIKE WITH PLANT HOMEODOMAIN AND RING FINGER DOMAINS 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BREAST CANCER; CANCER CELL; CELL CYCLE; CELL SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; COLONY FORMATION; CONTROLLED STUDY; DICENTRIC CHROMOSOME; DNA DAMAGE; DNA FRAGMENTATION; DNA REPAIR; DOWN REGULATION; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; UPREGULATION; WESTERN BLOTTING; X RAY;

ANIMALS; ANNEXIN A5; ANTIGENS, NUCLEAR; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TUMOR; DNA FRAGMENTATION; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HUMANS; MICE; NUCLEAR PROTEINS; RADIATION TOLERANCE;

MAMMALIA;

EID: 79952119225     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2011.530335     Document Type: Article

References (28)

1. Adams JM, Cory S. 2001. Life-or-death decisions by the Bcl-2 protein family. Trends in Biochemical Sciences 26:61-66. (Pubitemid 32124712)
2. Alhosin M, Abusnina A, Achour M, Sharif T, Muller C, Peluso J, Chataigneau T, Lugnier C, Schini-Kerth VB, Bronner C, Fuhrmann G. 2010. Induction of apoptosis by thymoquinone in lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent pathway which targets the epigenetic integrator UHRF1. Biochemical Pharmacology 79:1251-1260.
3. Arima Y, Hirota T, Bronner C, Mousli M, Fujiwara T, Niwa S, Ishikawa H, Saya H. 2004. Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1- dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes to Cells 9:131-142. (Pubitemid 38312957)
4. Bonapace IM, Latella L, Papait R, Nicassio F, Sacco A, Muto M, Crescenzi M, Di Fiore PP. 2002. NP95 is regulated by E1A during mitotic reactivation of terminally differentiated cells and is essential for S phase entry. The Journal of Cell Biology 157:909-914.
5. Bronner C, Achour M, Arima Y, Chataigneau T, Saya H, Schini- Kerth VB. 2007. The UHRF family: Oncogenes that are drugable targets for cancer therapy in the near future? Pharmacology & Therapeutics 115:419-434. (Pubitemid 47362377)
6. Fan S, Wang JA, Yuan RQ, Rockwell S, Andres J, Zlatapolskiy A, Goldberg ID, Rosen EM. 1998. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA damaging-agents Oncogene 17:131-141. (Pubitemid 28371886)
7. Freemont PS. 2000. RING for destruction? Current Biology 10:R84-87.
8. Fujimori A, Matsuda Y, Takemoto Y, Hashimoto Y, Kubo E, Araki R, Fukumura R, Mita K, Tatsumi K, Muto M. 1998. Cloning and mapping of NP95 gene which encodes a novel nuclear protein associated with cell proliferation. Mammalian Genome 9:1032-1035. (Pubitemid 29030909)
9. Jenkins Y, Markovtsov V, Lang W. 2005. Critical role of the ubiquitin ligase activity of NP95, a nuclear RING finger protein, in tumor cell growth. Molecular and Cellular Biology 16:5621-5629. (Pubitemid 41752212)
10. JinW, Chen L, Chen Y, Xu SG, Di GH, Yin WJ,Wu J, Shao ZM. 2010. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer. Breast Cancer Research and Treatment 123:359-373.
11. Joazeiro CA, Weissman AM. 2000. RING finger proteins: Mediators of ubiquitin ligase activity. Cell 102:549-552.
12. Han Z, Wang H, Hallahan DE. 2006. Radiation-guided gene therapy of cancer. Technology in Cancer Research & Treatment 5:437-444.
13. Hopfner R, Mousli M, Jeltsch JM, Voulgaris A, Lutz Y, Marin C, Bellocq JP, Oudet P, Bronner C. 2000. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression. Cancer Res 60:121-128. (Pubitemid 30058741)
14. Kim R. 200. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 103:1551-1560. (Pubitemid 40490015)
15. Koukourakis G. 2009. Radiation therapy for early breast cancer. Clinical & Translational Oncology 11:596-603.
16. Li XL,Meng QH, Fan SJ. 2009. Adenovirus-mediated expression of UHRF1 reduces the radiosensitivity of cervical cancer HeLa cells to gamma-irradiation. Acta Pharmacologica Sinica 30:458-466.
17. Miura M, Watanabe H, Sasaki T, Tatsumi K, Muto M. 2001. Dynamic changes in subnuclear NP95 location during the cell cycle and its spatial relationship with DNA replication foci. Experimental Cell Research 263:202-208. (Pubitemid 32989094)
18. Moran MS, Haffty BG. 2009. Radiation techniques and toxicities for locally advanced breast cancer. Seminars in Radiation Oncology 19:244-255.
19. Muto M, Kanari Y, Kubo E, Takabe T, Kurihara T, Fujimori A, Tatsumi K. 2002. Targeted disruption of NP95 gene renders murine embryonic stem cells hypersensitive to DNA damaging agents and DNA replication blocks. The Journal of Biological Chemistry 277:34549-34555.
20. Muto M, Fujimori A, Nenoi M. 2006. Isolation and characterization of a novel human radiosusceptibility gene, NP95. Radiation Research 166:723-733. (Pubitemid 44706609)
21. Pollard JM, Gatti RA. 2009. Clinical radiation sensitivity with DNA repair disorders: An overview. International Journal of Radiation Oncology, Biology, Physics 74:1323-1331.
22. Sharif T, Auger C, Alhosin M, Ebel C, Achour M, Etienne- Selloum N, Fuhrmann G, Bronner C, Schini-Kerth VB. 2010. Red wine polyphenols cause growth inhibition and apoptosis in acute lymphoblastic leukaemia cells by inducing a redoxsensitive up-regulation of p73 and down-regulation of UHRF1. European Journal of Cancer 46:983-994.
23. Thomadaki H, Scorilas A. 2006. BCL-2 family of apoptosisrelated genes: Functions and clinical implications in cancer. Critical Reviews in Clinical Laboratory Sciences 43:1-7.
24. Uemura T, Kubo E, Kanari Y, Ikemura T, Tatsumi K, Muto M. 2000. Temporal and spatial localization of novel nuclear protein NP95 in mitotic and meiotic cells. Cell Structure and Function 25:49-59.
25. Unoki M, Nishidate T, Nakamura Y. 2004. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene 23:7601-7610. (Pubitemid 39424918)
26. Unoki M, Brunet J, Mousli M. 2009a. Drug discovery targeting epigenetic codes: The great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis. Biochemical Pharmacology 78:1279-1288.
27. Unoki M, Kelly JD, Neal DE, Ponder BA, Nakamura Y, Hamamoto R. 2009b. UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer. British Journal of Cancer 101:98-105.
28. Walensky LD. 2006. BCL-2 in the crosshairs: Tipping the balance of life and death. Cell Death and Differentiation 13:1339-1350. (Pubitemid 44057469)